MetLife Investment Management’s Daseke, Inc. Common Stock DSKE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,335
| Closed | -$177K | – | 2958 |
|
|
2024
Q1 | $177K | Hold |
21,335
| – | – | ﹤0.01% | 2260 |
|
|
2023
Q4 | $173K | Hold |
21,335
| – | – | ﹤0.01% | 2320 |
|
|
2023
Q3 | $109K | Hold |
21,335
| – | – | ﹤0.01% | 2532 |
|
|
2023
Q2 | $152K | Hold |
21,335
| – | – | ﹤0.01% | 2433 |
|
|
2023
Q1 | $165K | Buy |
21,335
+5,904
| +38% | +$43.4K | ﹤0.01% | 2336 |
|
|
2022
Q4 | $87.8K | Sell |
15,431
-6,425
| -29% | -$37.9K | ﹤0.01% | 2642 |
|
|
2022
Q3 | $118K | Buy |
21,856
+5,252
| +32% | +$33.8K | ﹤0.01% | 2591 |
|
|
2022
Q2 | $106K | Sell |
16,604
-5,409
| -25% | -$41.3K | ﹤0.01% | 2688 |
|
|
2022
Q1 | $222K | Buy |
22,013
+15,689
| +248% | +$170K | ﹤0.01% | 2290 |
|
|
2021
Q4 | $63.5K | Sell |
6,324
-8,121
| -56% | -$79.8K | ﹤0.01% | 2462 |
|
|
2021
Q3 | $133K | Buy |
+14,445
| New | +$120K | ﹤0.01% | 2309 |
|
|
2021
Q2 | – | Sell |
-18,908
| Closed | -$161K | – | 2503 |
|
|
2021
Q1 | $161K | Sell |
18,908
-1,771
| -9% | -$10.9K | ﹤0.01% | 2163 |
|
|
2020
Q4 | $120K | Sell |
20,679
-607
| -3% | -$3.87K | ﹤0.01% | 2204 |
|
|
2020
Q3 | $114K | Buy |
+21,286
| New | +$109K | ﹤0.01% | 2156 |
|
|
2018
Q4 | – | Sell |
-19,836
| Closed | -$159K | – | 2603 |
|
|
2018
Q3 | $159K | Hold |
19,836
| – | – | ﹤0.01% | 2209 |
|
|
2018
Q2 | $197K | Buy |
19,836
+7,978
| +67% | +$74.3K | ﹤0.01% | 1928 |
|
|
2018
Q1 | $116K | Hold |
11,858
| – | – | ﹤0.01% | 2137 |
|
|
2017
Q4 | $169K | Buy |
+11,858
| New | +$159K | ﹤0.01% | 2014 |
|
MetLife Investment Management's DSKE Position: Q2 2024 in Review
MetLife Investment Management sold out of Daseke, Inc. Common Stock (DSKE) in Q2 2024, closing a stake of 21,335 shares — an estimated $177K sold.
MetLife Investment Management first reported a position in DSKE in Q4 2017 and held it in 18 quarters. The position peaked at $222K in Q1 2022. 0 funds tracked by Wall St. Rank hold DSKE as of Q2 2024.
- MetLife Investment Management reported no remaining Daseke, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- MetLife Investment Management sold 21,335 Daseke, Inc. Common Stock shares in Q2 2024, an estimated $177K.
- MetLife Investment Management first reported a position in Daseke, Inc. Common Stock in Q4 2017 and held it in 18 quarters.
- MetLife Investment Management's Daseke, Inc. Common Stock position peaked at $222K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Daseke, Inc. Common Stock as of Q2 2024.
Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.